DR LAL PATHLABS
Back to Income Statement
|
DR LAL PATHLABS Last 5 Year Consolidated Net Profit History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Consolidated Net Profit | ₹358 Cr | ₹239 Cr | ₹345 Cr | ₹292 Cr | ₹226 Cr |
What is the latest Consolidated Net Profit of DR LAL PATHLABS ?
| Year | Consolidated Net Profit |
|---|---|
| Mar2025 | ₹358 Cr |
| Mar2024 | ₹239 Cr |
| Mar2023 | ₹345 Cr |
| Mar2022 | ₹292 Cr |
| Mar2021 | ₹226 Cr |
How is Consolidated Net Profit of DR LAL PATHLABS Trending?
| Years | Consolidated Net Profit | % Change | |
|---|---|---|---|
| Mar2025 | ₹358 Cr | 49.78 | |
| Mar2024 | ₹239 Cr | -30.74 | |
| Mar2023 | ₹345 Cr | 18.25 | |
| Mar2022 | ₹292 Cr | 29.07 | |
| Mar2021 | ₹226 Cr | - | |
Compare Consolidated Net Profit of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹26,290.2 Cr | -2.2% | 3.1% | 2.8% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹112,527.0 Cr | -0.6% | -2.3% | 16.8% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹105,383.0 Cr | -1.7% | -6.5% | 9.1% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹69,467.5 Cr | -0.3% | -11.3% | 35.6% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹39,991.4 Cr | -1.8% | 13% | 57% | Stock Analytics | |
| GLOBAL HEALTH | ₹33,624.3 Cr | 4.3% | -7.1% | 16.7% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -2.2% |
3.1% |
2.8% |
| SENSEX | -0.1% |
0% |
9% |
You may also like the below Video Courses